Insights On CONTRACT PHARMA MANUFACTURING

  1. Building A Smarter Potency Strategy For Bispecific Antibodies 8/14/2026

    A biotech company needed a regulatory-ready potency strategy for a bispecific antibody. This organization combined orthogonal analytics with functional assays.

  2. Developing A Robust Crystallization Process For A High-Molecular-Weight Peptide 8/14/2026

    Scaling peptide crystallization is complex, with solid forms, polymorphic impurities, and solvent constraints all impacting quality and manufacturability.

  3. Characterizing AAV Payload With GMP-Compliant svAUC 8/14/2026

    Ensuring AAV quality starts with payload characterization. Learn why conventional methods may miss key capsid population insights.

  4. Revealing Hidden Integration Events With TLA And Nanopore Sequencing 8/14/2026

    When standard methods fell short, a biotech company used advanced analysis to confirm targeted construct integration and detect hidden genome changes.

  5. When Unexpected Particles Threaten Your Biologic 8/13/2026

    Particle contamination risks biologic safety. Advanced tools like Raman and SEM-EDS identify root causes fast to support robust, regulator-ready strategies that protect product quality.

  6. The Case For Non-Viral Circular Single-Stranded HDR Donors 8/13/2026

    Enable efficient, low-toxicity genome editing without viral vectors. This cell-free circular ssDNA platform preserves stem cell fitness while supporting scalable manufacturing.

  7. Reducing Risks In Biologics Manufacturing Through Predictive Modeling And PAT 8/12/2026

    Complex biologics development increasingly relies on adaptive, knowledge-driven strategies combining platform methods, targeted customization, high-throughput experimentation, and prior knowledge to accelerate IND readiness.

  8. 75 Years of Growth, Values, and Global Supply Resilience 8/12/2026

    Global expansion and supply chain flexibility are reducing risk and strengthening continuity. See how a multi-site strategy supports quality and customer success worldwide.

  9. GLP-1 Peptides Around The World 8/12/2026

    Explore how evolving regulations, supply constraints, and reimbursement models shape GLP-1 drug development across the U.S., Europe, and Asia.

  10. Accelerating Drug Development Through Integrated CDMO And CRO Partnership 8/12/2026

    Coordinating drug substance, analytics, and clinical ops across multiple vendors puts you in the integrator role. See how connected CDMO-CRO partnerships eliminate that burden and reduce downstream risk.